A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. The cornea ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD ...

Researchers estimate that more than 10 million people worldwide live with corneal blindness caused by disease or injury to the eye’s cornea. Unilateral limbal stem cell deficiency (LSCD) is a type of ...

For patients with severe corneal injuries, blindness has often been seen as a life sentence. But a new eye stem cell transplant may change that. Scientists at Massachusetts Eye and Ear have ...

BOSTON, Aug. 20, 2025 /PRNewswire/ -- Somite.ai, a company pioneering foundation models for human stem cells, today announced a strategic investment from AMD Ventures, following Somite's $47M Series A ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections, can ...

Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers estimate ...